Ultrasound-Mediated Blood-Brain Barrier Opening Improves Whole Brain Gene Delivery in Mice

Marie‐Solenne Félix(Inserm), Jean‐Christophe Roux(Inserm), Anthony Novell(Centre National de la Recherche Scientifique), Serge Mensah(Centre National de la Recherche Scientifique), Ambre Dauba(Centre National de la Recherche Scientifique), Emilie Borloz(Inserm), Yann Ehinger(Inserm), Khaled Metwally(Centre National de la Recherche Scientifique), Laurent Villard(Inserm), Valérie Matagne(Inserm), Benoît Larrat(Centre National de la Recherche Scientifique)
Pharmaceutics
August 12, 2021
10.3390/pharmaceutics13081245
Cited by 42

Related Papers

Mutations in GRIN2A and GRIN2B encoding regulatory subunits of NMDA receptors cause variable neurodevelopmental phenotypes
|Nature Genetics|2010|509
A non-hallucinogenic psychedelic analogue with therapeutic potential
|Nature|2020|473
Molecular and clinical descriptions of patients with <scp>GABA<sub>A</sub></scp> receptor gene variants (<i><scp>GABRA1</scp>, <scp>GABRB2</scp>, <scp>GABRB3</scp>, <scp>GABRG2</scp></i>): A cohort study, review of literature, and genotype–phenotype correlation
|Epilepsia|2022|80
Epileptic patients with de novo <i><scp>STXBP</scp>1</i> mutations: Key clinical features based on 24 cases
|Epilepsia|2015|67
Severe offtarget effects following intravenous delivery of AAV9-MECP2 in a female mouse model of Rett syndrome
|Neurobiology of Disease|2020|58